Umicore Past Earnings Performance
Past criteria checks 0/6
Umicore's earnings have been declining at an average annual rate of -17.4%, while the Chemicals industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 2.4% per year.
Key information
-17.4%
Earnings growth rate
-17.4%
EPS growth rate
| Chemicals Industry Growth | 12.4% |
| Revenue growth rate | 2.4% |
| Return on equity | -69.0% |
| Net Margin | -8.3% |
| Next Earnings Update | 14 Feb 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Umicore makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 15,715 | -1,310 | 0 | 0 |
| 31 Mar 24 | 16,998 | -463 | 0 | 0 |
| 31 Dec 23 | 18,280 | 385 | 0 | 0 |
| 30 Sep 23 | 20,426 | 435 | 0 | 0 |
| 30 Jun 23 | 22,571 | 484 | 0 | 0 |
| 31 Mar 23 | 24,010 | 527 | 0 | 0 |
| 31 Dec 22 | 25,449 | 570 | 0 | 0 |
| 30 Sep 22 | 24,863 | 549 | 0 | 0 |
| 30 Jun 22 | 24,278 | 528 | 0 | 0 |
| 31 Mar 22 | 24,172 | 573 | 0 | 0 |
| 31 Dec 21 | 24,066 | 619 | 0 | 0 |
| 30 Sep 21 | 23,746 | 529 | 0 | 0 |
| 30 Jun 21 | 23,427 | 440 | 0 | 0 |
| 31 Mar 21 | 22,072 | 285 | 0 | 0 |
| 31 Dec 20 | 20,716 | 131 | 0 | 0 |
| 30 Sep 20 | 20,298 | 180 | 0 | 0 |
| 30 Jun 20 | 19,880 | 230 | 0 | 0 |
| 31 Mar 20 | 18,687 | 259 | 0 | 0 |
| 31 Dec 19 | 17,494 | 288 | 0 | 0 |
| 30 Sep 19 | 16,223 | 296 | 0 | 0 |
| 30 Jun 19 | 14,953 | 304 | 0 | 0 |
| 31 Mar 19 | 14,339 | 311 | 0 | 0 |
| 31 Dec 18 | 13,726 | 317 | 0 | 0 |
| 30 Sep 18 | 12,895 | 291 | 0 | 0 |
| 30 Jun 18 | 12,063 | 265 | 0 | 0 |
| 31 Mar 18 | 12,010 | 240 | 0 | 0 |
| 31 Dec 17 | 11,957 | 215 | 0 | 0 |
| 30 Sep 17 | 11,913 | 204 | 0 | 0 |
| 30 Jun 17 | 11,870 | 194 | 0 | 0 |
| 31 Mar 17 | 11,157 | 187 | 0 | 0 |
| 31 Dec 16 | 10,444 | 181 | 0 | 0 |
| 30 Sep 16 | 9,957 | 175 | 0 | 0 |
| 30 Jun 16 | 9,471 | 168 | 0 | 0 |
| 31 Mar 16 | 9,584 | 161 | 0 | 0 |
| 31 Dec 15 | 9,698 | 153 | 0 | 0 |
| 30 Sep 15 | 9,957 | 175 | 0 | 0 |
| 30 Jun 15 | 9,161 | 170 | 0 | 0 |
| 31 Mar 15 | 8,643 | 163 | 0 | 0 |
| 31 Dec 14 | 8,125 | 156 | 0 | 0 |
| 30 Sep 14 | 8,467 | 158 | 0 | 0 |
| 30 Jun 14 | 8,441 | 159 | 0 | 0 |
| 31 Mar 14 | 9,130 | 169 | 0 | 0 |
| 31 Dec 13 | 9,819 | 179 | 0 | 0 |
Quality Earnings: NVJ is currently unprofitable.
Growing Profit Margin: NVJ is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NVJ is unprofitable, and losses have increased over the past 5 years at a rate of 17.4% per year.
Accelerating Growth: Unable to compare NVJ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NVJ is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (5%).
Return on Equity
High ROE: NVJ has a negative Return on Equity (-69.01%), as it is currently unprofitable.